Related Experiment Videos
Alkylphosphocholines: a new class of membrane-active anticancer agents
Cancer Chemotherapy and Pharmacology
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Development and application of three-dimensional skin equivalents for the investigation of percutaneous worm invasion.
Experimental parasitology·2015
Pharmacological insight into the anti-inflammatory activity of sesquiterpene lactones from Neurolaena lobata (L.) R.Br. ex Cass.
Phytomedicine : international journal of phytotherapy and phytopharmacology·2014
Laser assisted cell printing.
Current pharmaceutical biotechnology·2013
Circulatory compromise as a potential mechanism of fatal hepatic failure during long-term selpercatinib therapy: pharmacokinetic and clinical insights.
Cancer chemotherapy and pharmacology·2026
CDCP1-targeted antibody-drug conjugates and immunocytokines for cancer therapy.
Cancer chemotherapy and pharmacology·2026
Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial.
Cancer chemotherapy and pharmacology·2026
A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.
Cancer chemotherapy and pharmacology·2026
Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.
Cancer chemotherapy and pharmacology·2026
Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma.
Cancer chemotherapy and pharmacology·2026
Benzophenone Derivatives as a New Class of Anti-Infectives Against Acanthamoeba spp.
Archiv der Pharmazie·2026
Novel 1H-Indole-3-carboxamide Derivatives as CDK4 Inhibitors for Treating Cancer.
ACS medicinal chemistry letters·2026
Novel Heterocyclic Compounds for Treating HIV Infection.
ACS medicinal chemistry letters·2026
Novel 6,5-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.
ACS medicinal chemistry letters·2026